Cointime

Download App
iOS & Android

Bluebird Bio

company
Funding Round
Post-IPO Equity
Money Raised
$ 113.55M
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion

Historical Financing

Announced Date Round Money Raised Investors
Jul 25, 2012 Series D $ 60M ARCH Venture Partners,ArmaVir Partners,etc. Detail
Apr 20, 2011 Series C $ 30M ARCH Venture Partners,Easton Capital,etc. Detail
Jun 17, 2004 Series A $ 8.50M ABN AMRO Fund,Nazem and Company Detail
Oct 27, 2012 Series Unknown $ 9.30M California Institute for Regenerative Medicine Detail
Mar 12, 2010 Series B $ 35M Easton Capital,Forbion Capital Partners,etc. Detail
Dec 7, 2016 Post-IPO Equity $ 250M Detail
Oct 7, 2004 Series Unknown $ 12M ABN AMRO Fund,Easton Capital,etc. Detail
Mar 16, 2011 Grant $ 4.20M Detail
Sep 8, 2021 Post-IPO Equity $ 75M Detail
Jun 14, 2019 IPO 0 Detail